Account
AdClear bags digital mandate for Value Research
Mumbai: Independent digital marketing agency AdClear has bagged the digital mandate for Value Research – an investment research company in India that empowers savers to invest wisely and achieve their lives’ financial goals.
“Value Research has been guiding Indian investors since 1990. We are embarking on an ambitious plan to reach a substantially larger investor base with our unique perspective,” stated Value Research CEO Dhirendra Kumar. “We have chosen Ad Clear to help us with digital initiatives encompassing brand knowledge and growth.”
As part of the mandate, AdClear will be handling the entire digital marketing duties which include social, SEO and performance – this with the objective of giving the brand a robust online presence that will help it conquer new markets and move younger audiences towards planned investment, said the statement.
“Value research is the most trusted name in India when it comes to investment advice. Its opinion is rooted in deep research, 29 years of experience and an inclination towards simplifying complex financial choices,” said AdClear CEO Gurbir Singh. “We are excited to partner Value Research and help it inculcate better financial decisions in a large but not yet fully tapped market.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
